Erste Asset Management’s Immunovant IMVT Stock Holding History

Erste Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Hold	144,500	–	–	0.04%	288
2026 Q1	$3.4M	Buy	144,500 +16,000	+12%	+$414K	0.03%	307
2025 Q4	$3.29M	Buy	128,500 +76,000	+145%	+$1.69M	0.03%	305
2025 Q3	$843K	Hold	52,500	–	–	0.01%	431
2025 Q2	$845K	Hold	52,500	–	–	0.01%	534
2025 Q1	$964K	Hold	52,500	–	–	0.01%	380
2024 Q4	$1.29M	Hold	52,500	–	–	0.02%	362
2024 Q3	$1.47M	Buy	52,500 +7,000	+15%	+$206K	0.02%	352
2024 Q2	$1.18M	Hold	45,500	–	–	0.02%	356
2024 Q1	$1.48M	Hold	45,500	–	–	0.02%	331
2023 Q4	$1.93M	Buy	+45,500	New	+$1.67M	0.03%	298

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Erste Asset Management's IMVT Position: Q2 2026 in Review

Erste Asset Management held its Immunovant (IMVT) position steady in Q2 2026 at 144,500 shares worth $5.56M. The position accounts for 0.04% of the portfolio, ranked #288.

Erste Asset Management first reported a position in IMVT in Q4 2023 and has held it in 11 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Erste Asset Management held 144,500 shares of Immunovant worth $5.56M as of Q2 2026.
Erste Asset Management left its Immunovant share count unchanged in Q2 2026.
Immunovant made up 0.04% of Erste Asset Management's portfolio in Q2 2026, its #288 holding.
Erste Asset Management first reported a position in Immunovant in Q4 2023 and has held it in 11 quarters since.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.